- Home
- ZBIO vs EWCZ Comparison
ZBIO vs EWCZ Comparison
Compare ZBIO & EWCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- EWCZ
- Stock Information
- Founded
- ZBIO 2019
- EWCZ 2004
- Country
- ZBIO United States
- EWCZ United States
- Employees
- ZBIO N/A
- EWCZ N/A
- Industry
- ZBIO
- EWCZ Package Goods/Cosmetics
- Sector
- ZBIO
- EWCZ Consumer Discretionary
- Exchange
- ZBIO NYSE
- EWCZ Nasdaq
- Market Cap
- ZBIO 268.7M
- EWCZ 300.3M
- IPO Year
- ZBIO 2024
- EWCZ 2021
- Fundamental
- Price
- ZBIO $7.83
- EWCZ $6.57
- Analyst Decision
- ZBIO Strong Buy
- EWCZ Buy
- Analyst Count
- ZBIO 6
- EWCZ 7
- Target Price
- ZBIO $29.20
- EWCZ $6.64
- AVG Volume (30 Days)
- ZBIO 207.0K
- EWCZ 378.5K
- Earning Date
- ZBIO 03-04-2025
- EWCZ 03-05-2025
- Dividend Yield
- ZBIO N/A
- EWCZ N/A
- EPS Growth
- ZBIO N/A
- EWCZ 62.57
- EPS
- ZBIO N/A
- EWCZ 0.23
- Revenue
- ZBIO N/A
- EWCZ $223,500,000.00
- Revenue This Year
- ZBIO N/A
- EWCZ $1.26
- Revenue Next Year
- ZBIO N/A
- EWCZ $2.40
- P/E Ratio
- ZBIO N/A
- EWCZ $28.56
- Revenue Growth
- ZBIO N/A
- EWCZ 2.42
- 52 Week Low
- ZBIO $5.83
- EWCZ $4.80
- 52 Week High
- ZBIO $26.25
- EWCZ $15.50
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- EWCZ 45.45
- Support Level
- ZBIO N/A
- EWCZ $6.74
- Resistance Level
- ZBIO N/A
- EWCZ $7.60
- Average True Range (ATR)
- ZBIO 0.00
- EWCZ 0.31
- MACD
- ZBIO 0.00
- EWCZ -0.04
- Stochastic Oscillator
- ZBIO 0.00
- EWCZ 2.83
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.